CIK 0000059478
- Large accelerated filer
ELI LILLY & Co
Sign in to watch- Ticker
- LLY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- IN
- Entity type
- Operating
- EIN
- 350470950
- Phone
- +1 317-276-2000
- Business address
- LILLY CORPORATE CTR, DROP CODE 1094, INDIANAPOLIS, IN, 46285
- Former names
- LILLY ELI & CO, LILLY ELI & CO ET AL
- 4 Grant or award Director acquired 7.1 shares (grant or award)
- 4 Grant or award Director acquired 21.25 shares (grant or award)
- 4 Grant or award Director acquired 14.21 shares (grant or award)
- 4 Grant or award Director acquired 14.21 shares (grant or award)
- 4 Grant or award Director acquired 16.83 shares (grant or award)
- 4 Open-market buy EVP & CFO bought 715 shares at $691.79 ($494,627)
- 4 Open-market buy Director bought 758 shares at $660.25 ($500,473)
- 4 Open-market buy EVP & Pres., Lilly Oncology bought 1,000 shares at $647.36 ($647,360)
- 4 Open-market buy President, Chair, and CEO bought 1,632 shares at $644.77 ($1,052,263)
- 4 Open-market buy EVP, CSO & Pres. LRL & LLY Imm bought 1,000 shares at $634.41 ($634,405)
- 4 Open-market buy Director bought 117 shares at $641.18 ($75,018)
- 4 Open-market buy Director bought 1,565 shares at an average $642.33 ($1,005,242)
- 4 Planned sale EVP&Pres, LLY USA&Global Capab sold 1,250 shares at $627.01 ($783,763)
- 4 Open-market buy Director bought 200 shares at $639.56 ($127,913)
- 4 Shares withheld for taxes EVP, Global Quality gave up 426.92 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 280,000 shares at an average $805.07 ($225,419,259)
- 4 Grant or award Director acquired 19.46 shares (grant or award)
- 4 Grant or award Director acquired 6.51 shares (grant or award)
- 4 Grant or award Director acquired 13.01 shares (grant or award)
- 4 Grant or award Director acquired 13.01 shares (grant or award)
Page 9 of 142 · 2,824 filings